XOMA Corporation (XOMAP)
Valuation Overview•Is XOMA Corporation Overvalued or Undervalued?
Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Moderate quality score of 63/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Solid fundamental quality, though solvency presents a headwind.
Wall Street sentiment is generally neutral. This outlook is strongly supported by highly attractive capital returns, driven predominantly by aggressive share repurchases.
XOMAP demonstrates strong business quality with robust profitability and healthy margins. However, the balance sheet carries elevated leverage, requiring careful monitoring of debt servicing capabilities.
The company is driving exceptional top-line expansion (105.3% 3Y CAGR) paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 18.1% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $12.3M | +83.1% | +105.3% | +12.2% | -0.6% | |
| EBITDA | $415K | — | — | — | — | |
| Net Income | $4.5M | +329.4% | — | — | — | |
| EPS (Diluted) | $0.17 | +188.5% | — | +13.4% | — | |
| Free Cash Flow | $6.0M | +120.9% | — | -20.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 94.3% | 96.9% | 97.1% | 90.6% |
| Operating Margin | 18.1% | -332.7% | -248.2% | -261.2% |
| Net Margin | 123.3% | -282.0% | -217.7% | -224.0% |
| FCF Margin | 24.2% | -141.6% | -180.3% | -210.1% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.13 | $0.17 | +30.5% | ||
| Q1'26 | $-0.11 | $0.26 | +327.0% | ||
| Q4'25 | $-0.04 | $0.78 | +2050.0% | ||
| Q3'25 | $-0.15 | $0.61 | +508.7% | ||
| Q2'25 | $-0.24 | $0.20 | +183.2% | ||
| Q1'25 | $-0.29 | $-0.33 | -16.5% | ||
| Q4'24 | — | $-1.47 | — | ||
| Q3'24 | — | $0.92 | — |
Total return is +7.7% (1Y), lagging the benchmark by -13.2%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -2.1% | -9.4% | — |
| 1Y | +7.7% | -13.2% | +8.4% |
| 3YCAGR | +9.8% | -9.1% | +26.8% |
| 5YCAGR | +6.6% | -4.6% | +41.0% |
| 10YCAGR | +4.2% | -9.5% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about XOMA Corporation (XOMAP) valuation, health, and returns.
Based on peer relative multiples, XOMA Corporation appears Slightly expensive versus peers compared to industry peers.
XOMA Corporation has multiple valuation anchors: Peer Relative Fair Value: $21.08. A convergence of these signals offers higher conviction.
XOMA Corporation displays good financial health with a composite quality score of 63/100, supported by a Altman Z-Score of -5.2 (distress zone), Piotroski F-Score of 5/9, Return on Invested Capital (ROIC) of 6.8%.
XOMA Corporation pays a 1.2% dividend yield, covered by a 0% payout ratio with 0 years of growth, supplemented by a 5.2% buyback yield.
XOMA Corporation's current growth trajectory is Decelerating. The company achieved +83.1% 1Y revenue growth and +188.5% 1Y EPS growth, compared to its 3Y revenue CAGR of +105.3%.
Wall Street consensus is Buy based on 9 analysts, beating EPS expectations in 83% of recent quarters with a 5-quarter streak. The consensus price target represents a N/A change from current levels.
Investment risks for XOMA Corporation include: -7.4% 1-year max drawdown, elevated distress risk. Volatility risk is characterized by a beta of 0.02x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.